Response to: Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan

Rafferty, Ellen; Yaghoubi, Mohsen; Taylor, Jeff; Farag, Marwa

doi:10.1186/s12962-018-0159-y

Cited by 3 publications

(3 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Savings of $1.3 to $2.6 million per year are projected for the ve provinces. Rafferty's study focused on the province of Saskatchewan, Canada, and supports these results [30]. The pharmacists prescribing for minor ailments program saved approximately $800,000 in 2014 from the societal perspective.…”

Section: Cost-effectiveness Of the Pharmacist Independent Prescriber ...mentioning

confidence: 73%

See 1 more Smart Citation

The community pharmacist as an independent prescriber: A scoping review

Piraux,

Bonnan,

Ramond-Roquin

et al. 2024

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

Section: Cost-effectiveness Of the Pharmacist Independent Prescriber ...mentioning

confidence: 73%

“…A strong signal was observed in this scoping review regarding the cost-effectiveness of the PIP model [27,29,30].…”

Section: Health Bene Ts and Safety For Patientsmentioning

confidence: 77%

The community pharmacist as an independent prescriber: A scoping review

Piraux,

Bonnan,

Ramond-Roquin

et al. 2024

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

“…Following publication of the original article [1], these errors were flagged:The article title was missing ‘Response to’.The article was linked to its associated articles incorrectly.…”

Section: Correction To: Cost Eff Resour Alloc (2018) 16:62 101186/s1mentioning

confidence: 99%

Correction to: Response to: Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan

Rafferty

Yaghoubi

Taylor

et al. 2019

Cost Eff Resour Alloc

Self Cite

View full text Add to dashboard Cite

The community pharmacist as an independent prescriber: a scoping review

Piraux

Bonnan

Ramond-Roquin

et al. 2023

Preprint

View full text Add to dashboard Cite

Background Due to the shortage of professionals, the ever-increasing needs and demands for appointments, consultation of physicians is getting harder, and delays are getting longer. To limit this issue, several countries have experimented different models of independent prescribing through pharmacies. Aim This study aimed to analyze the contribution of independent prescribing by community pharmacists, in primary care, using the micro, meso, macro level framework. Method Three different databases were used: Medline, Scopus and Embase. The search was executed on March 23rd, 2022, for each of them. Some relevant articles were added manually to the search. To be selected for the review, articles needed to be published after 2000, written in English or French, focus on independent prescribing by community pharmacists, and concern a minor condition. Original research was accepted. Articles were imported into the Covidence systematic review software to perform the review. Results The search resulted in 1768 articles and 846 after removing duplicates. After title and abstract screening, 792 articles were qualified as irrelevant, and 54 full text studies were reviewed for eligibility. Finally, eight studies were included in the scoping review. The various studies included are recent (from 2013 to 2021) and mostly of Canadian origin (6/8). For five of them, a quantitative study design is observed. As an independent prescriber, the community pharmacist can improve patient access to primary care, reducing consultation delays for minor conditions. In addition, patient safety is maintained, and the patient’s quality of life is increased. The pharmacist independent prescriber model seems to be cost-effective for society. Conclusion This review highlights the potential value and relevance of the pharmacist independent prescriber. The benefits to society are felt at all levels: micro, meso, and macro. Effectiveness and efficacy seem established, but further studies are needed in other fields, as efficiency.

show abstract

Response to: Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan

Cited by 3 publications

References 19 publications

The community pharmacist as an independent prescriber: A scoping review

The community pharmacist as an independent prescriber: A scoping review

Correction to: Response to: Costs and savings associated with a pharmacists prescribing for minor ailments program in Saskatchewan

The community pharmacist as an independent prescriber: a scoping review

Contact Info

Product

Resources

About